Versions of Schedule

[Repealed, 2012, c. 1, s. 45] Methylphenidate (methyl 2-phenyl-2-(piperidin-2-yl)acetate), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues, including Ethylphenidate (ethyl 2-phenyl-2-(piperidin-2-yl)acetate) Isopropylphenidate (isopropyl 2-phenyl-2-(piperidin-2-yl)acetate) Propylphenidate (propyl 2-phenyl-2-(piperidin-2-yl)acetate) 3,4-Dichloromethylphenidate (methyl 2-(3,4-dichlorophenyl)-2-(piperidin-2-yl)acetate) 4-Methylmethylphenidate (methyl 2-(4-methylphenyl)-2-(piperidin-2-yl)acetate) 4-Fluoromethylphenidate (methyl 2-(4-fluorophenyl)-2-(piperidin-2-yl)acetate) Methylnaphthidate (methyl 2-(naphthalen-2-yl)-2-(piperidin-2-yl)acetate) Ethylnaphthidate (ethyl 2-(naphthalen-2-yl)-2-(piperidin-2-yl)acetate) Methaqualone (2–methyl–3–(2–methylphenyl)–4(3H)–quinazolinone) and any salt thereof Mecloqualone (2–methyl–3–(2–chlorophenyl)–4(3H)–quinazolinone) and any salt thereof Lysergic acid diethylamide (LSD) (N,N–diethyllysergamide) and any salt thereof N,N–Diethyltryptamine (DET) (3–[(2–diethylamino) ethyl]indole) and any salt thereof N,N–Dimethyltryptamine (DMT) (3–[(2–dimethylamino) ethyl]indole) and any salt thereof N–Methyl–3–piperidyl benzilate (LBJ) (3–[(hydroxydiphenylacetyl)oxy]–1–methylpiperidine) and any salt thereof Harmaline (4,9–dihydro–7–methoxy–1–methyl–3H–pyrido(3,4–b)indole) and any salt thereof Harmalol (4,9–dihydro–1–methyl–3H–pyrido(3,4–b)indol–7–ol) and any salt thereof Psilocin (3–[2–(dimethylamino)ethyl]–4–hydroxyindole) and any salt thereof Psilocybin (3–[2–(dimethylamino)ethyl]–4–phosphoryloxyindole) and any salt thereof N–(1–phenylcyclohexyl)ethylamine (PCE) and any salt thereof 1–[1–(2–Thienyl) cyclohexyl]piperidine (TCP) and any salt thereof 1–Phenyl–N–propylcyclohexanamine and any salt thereof Rolicyclidine (1-(1-phenylcyclohexyl) pyrrolidine) and any salt thereof Mescaline (3,4,5–trimethoxybenzeneethanamine) and any salt thereof, but not peyote (lophophora) 4–Methylaminorex (4,5–dihydro–4–methyl–5–phenyl–2–oxazolamine) and any salt thereof Cathinone ((-)-α-aminopropiophenone) and its salts Fenetylline (d,l–3,7–dihydro–1,3–dimethyl–7–(2–[(1–methyl–2–phenethyl)amino]ethyl)–1H–purine–2, 6–dione) and any salt thereof 2–Methylamino–1–phenyl–1–propanone and any salt thereof 1–[1–(Phenylmethyl)cyclohexyl]piperidine and any salt thereof 1–[1–(4–Methylphenyl)cyclohexyl]piperidine and any salt thereof[Repealed, SOR/2016-73, s. 1][Repealed, 2012, c. 1, s. 46] Aminorex (4,5-dihydro-5-phenyl-2-oxazolamine) and any salt thereof Etryptamine (3-(2-aminobutyl)indole) and any salt thereof Lefetamine ((-)-N,N-dimethyl-α-phenylbenzeneethanamine), its salts, derivatives and isomers and salts of derivatives and isomers Mesocarb (3-(α-methylphenethyl)-N-(phenylcarbamoyl)sydnone imine) and any salt thereof Zipeprol (4-(2-methoxy-2-phenylethyl)-α-(methoxyphenylmethyl)-1-piperazineethanol) and any salt thereof Amineptine (7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) and any salt thereof Benzylpiperazine [BZP], namely 1-benzylpiperazine and its salts, isomers and salts of isomers Trifluoromethylphenylpiperazine [TFMPP], namely 1-(3-trifluoromethylphenyl)piperazine and its salts, isomers and salts of isomers 2C-phenethylamines and their salts, derivatives, isomers and salts of derivatives and isomers that correspond to the following chemical description : any substance that has a 1-amino-2-phenylethane structure substituted at the 2’ and 5’ or 2’ and 6’ positions of the benzene ring by an alkoxy or haloalkoxy group, or substituted at two adjacent carbon atoms of the benzene ring which results in the formation of a furan, dihydrofuran, pyran, dihydropyran or methylenedioxy group — whether or not further substituted on the benzene ring to any extent, whether or not substituted at the amino group by one or two, or a combination of, methyl, ethyl, propyl, isopropyl, hydroxyl, benzyl (or benzyl substituted to any extent) or benzylene (or benzylene substituted to any extent) groups and whether or not substituted at the 2-ethyl (beta carbon) position by a hydroxyl, oxo or alkoxy group — and its salts and derivatives and salts of derivatives, including 4-bromo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25B-NBOMe) 4-chloro-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25C-NBOMe) 4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe) 4-bromo-2,5-dimethoxybenzeneethanamine (2C-B)

[Repealed, 2012, c. 1, s. 45] Methylphenidate (α–phenyl–2–piperidineacetic acid methyl ester) and any salt thereof Methaqualone (2–methyl–3–(2–methylphenyl)–4(3H)–quinazolinone) and any salt thereof Mecloqualone (2–methyl–3–(2–chlorophenyl)–4(3H)–quinazolinone) and any salt thereof Lysergic acid diethylamide (LSD) (N,N–diethyllysergamide) and any salt thereof N,N–Diethyltryptamine (DET) (3–[(2–diethylamino) ethyl]indole) and any salt thereof N,N–Dimethyltryptamine (DMT) (3–[(2–dimethylamino) ethyl]indole) and any salt thereof N–Methyl–3–piperidyl benzilate (LBJ) (3–[(hydroxydiphenylacetyl)oxy]–1–methylpiperidine) and any salt thereof Harmaline (4,9–dihydro–7–methoxy–1–methyl–3H–pyrido(3,4–b)indole) and any salt thereof Harmalol (4,9–dihydro–1–methyl–3H–pyrido(3,4–b)indol–7–ol) and any salt thereof Psilocin (3–[2–(dimethylamino)ethyl]–4–hydroxyindole) and any salt thereof Psilocybin (3–[2–(dimethylamino)ethyl]–4–phosphoryloxyindole) and any salt thereof N–(1–phenylcyclohexyl)ethylamine (PCE) and any salt thereof 1–[1–(2–Thienyl) cyclohexyl]piperidine (TCP) and any salt thereof 1–Phenyl–N–propylcyclohexanamine and any salt thereof Rolicyclidine (1-(1-phenylcyclohexyl) pyrrolidine) and any salt thereof Mescaline (3,4,5–trimethoxybenzeneethanamine) and any salt thereof, but not peyote (lophophora) 4–Methylaminorex (4,5–dihydro–4–methyl–5–phenyl–2–oxazolamine) and any salt thereof Cathinone ((-)-α-aminopropiophenone) and its salts Fenetylline (d,l–3,7–dihydro–1,3–dimethyl–7–(2–[(1–methyl–2–phenethyl)amino]ethyl)–1H–purine–2, 6–dione) and any salt thereof 2–Methylamino–1–phenyl–1–propanone and any salt thereof 1–[1–(Phenylmethyl)cyclohexyl]piperidine and any salt thereof 1–[1–(4–Methylphenyl)cyclohexyl]piperidine and any salt thereof[Repealed, SOR/2016-73, s. 1][Repealed, 2012, c. 1, s. 46] Aminorex (4,5-dihydro-5-phenyl-2-oxazolamine) and any salt thereof Etryptamine (3-(2-aminobutyl)indole) and any salt thereof Lefetamine ((-)-N,N-dimethyl-α-phenylbenzeneethanamine), its salts, derivatives and isomers and salts of derivatives and isomers Mesocarb (3-(α-methylphenethyl)-N-(phenylcarbamoyl)sydnone imine) and any salt thereof Zipeprol (4-(2-methoxy-2-phenylethyl)-α-(methoxyphenylmethyl)-1-piperazineethanol) and any salt thereof Amineptine (7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) and any salt thereof Benzylpiperazine [BZP], namely 1-benzylpiperazine and its salts, isomers and salts of isomers Trifluoromethylphenylpiperazine [TFMPP], namely 1-(3-trifluoromethylphenyl)piperazine and its salts, isomers and salts of isomers 2C-phenethylamines and their salts, derivatives, isomers and salts of derivatives and isomers that correspond to the following chemical description : any substance that has a 1-amino-2-phenylethane structure substituted at the 2’ and 5’ or 2’ and 6’ positions of the benzene ring by an alkoxy or haloalkoxy group, or substituted at two adjacent carbon atoms of the benzene ring which results in the formation of a furan, dihydrofuran, pyran, dihydropyran or methylenedioxy group — whether or not further substituted on the benzene ring to any extent, whether or not substituted at the amino group by one or two, or a combination of, methyl, ethyl, propyl, isopropyl, hydroxyl, benzyl (or benzyl substituted to any extent) or benzylene (or benzylene substituted to any extent) groups and whether or not substituted at the 2-ethyl (beta carbon) position by a hydroxyl, oxo or alkoxy group — and its salts and derivatives and salts of derivatives, including 4-bromo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25B-NBOMe) 4-chloro-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25C-NBOMe) 4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe) 4-bromo-2,5-dimethoxybenzeneethanamine (2C-B)

[Repealed, 2012, c. 1, s. 45] Methylphenidate (α–phenyl–2–piperidineacetic acid methyl ester) and any salt thereof Methaqualone (2–methyl–3–(2–methylphenyl)–4(3H)–quinazolinone) and any salt thereof Mecloqualone (2–methyl–3–(2–chlorophenyl)–4(3H)–quinazolinone) and any salt thereof Lysergic acid diethylamide (LSD) (N,N–diethyllysergamide) and any salt thereof N,N–Diethyltryptamine (DET) (3–[(2–diethylamino) ethyl]indole) and any salt thereof N,N–Dimethyltryptamine (DMT) (3–[(2–dimethylamino) ethyl]indole) and any salt thereof N–Methyl–3–piperidyl benzilate (LBJ) (3–[(hydroxydiphenylacetyl)oxy]–1–methylpiperidine) and any salt thereof Harmaline (4,9–dihydro–7–methoxy–1–methyl–3H–pyrido(3,4–b)indole) and any salt thereof Harmalol (4,9–dihydro–1–methyl–3H–pyrido(3,4–b)indol–7–ol) and any salt thereof Psilocin (3–[2–(dimethylamino)ethyl]–4–hydroxyindole) and any salt thereof Psilocybin (3–[2–(dimethylamino)ethyl]–4–phosphoryloxyindole) and any salt thereof N–(1–phenylcyclohexyl)ethylamine (PCE) and any salt thereof 1–[1–(2–Thienyl) cyclohexyl]piperidine (TCP) and any salt thereof 1–Phenyl–N–propylcyclohexanamine and any salt thereof Rolicyclidine (1-(1-phenylcyclohexyl) pyrrolidine) and any salt thereof Mescaline (3,4,5–trimethoxybenzeneethanamine) and any salt thereof, but not peyote (lophophora) 4–Methylaminorex (4,5–dihydro–4–methyl–5–phenyl–2–oxazolamine) and any salt thereof Cathinone ((–)–α–aminopropiophenone) and any salt thereof Fenetylline (d,l–3,7–dihydro–1,3–dimethyl–7–(2–[(1–methyl–2–phenethyl)amino]ethyl)–1H–purine–2, 6–dione) and any salt thereof 2–Methylamino–1–phenyl–1–propanone and any salt thereof 1–[1–(Phenylmethyl)cyclohexyl]piperidine and any salt thereof 1–[1–(4–Methylphenyl)cyclohexyl]piperidine and any salt thereof[Repealed, SOR/2016-73, s. 1][Repealed, 2012, c. 1, s. 46] Aminorex (4,5-dihydro-5-phenyl-2-oxazolamine) and any salt thereof Etryptamine (3-(2-aminobutyl)indole) and any salt thereof Lefetamine ((-)-N,N-dimethyl-α-phenylbenzeneethanamine), its salts, derivatives and isomers and salts of derivatives and isomers Mesocarb (3-(α-methylphenethyl)-N-(phenylcarbamoyl)sydnone imine) and any salt thereof Zipeprol (4-(2-methoxy-2-phenylethyl)-α-(methoxyphenylmethyl)-1-piperazineethanol) and any salt thereof Amineptine (7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) and any salt thereof Benzylpiperazine [BZP], namely 1-benzylpiperazine and its salts, isomers and salts of isomers Trifluoromethylphenylpiperazine [TFMPP], namely 1-(3-trifluoromethylphenyl)piperazine and its salts, isomers and salts of isomers 2C-phenethylamines and their salts, derivatives, isomers and salts of derivatives and isomers that correspond to the following chemical description : any substance that has a 1-amino-2-phenylethane structure substituted at the 2’ and 5’ or 2’ and 6’ positions of the benzene ring by an alkoxy or haloalkoxy group, or substituted at two adjacent carbon atoms of the benzene ring which results in the formation of a furan, dihydrofuran, pyran, dihydropyran or methylenedioxy group — whether or not further substituted on the benzene ring to any extent, whether or not substituted at the amino group by one or two, or a combination of, methyl, ethyl, propyl, isopropyl, hydroxyl, benzyl (or benzyl substituted to any extent) or benzylene (or benzylene substituted to any extent) groups and whether or not substituted at the 2-ethyl (beta carbon) position by a hydroxyl, oxo or alkoxy group — and its salts and derivatives and salts of derivatives, including 4-bromo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25B-NBOMe) 4-chloro-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25C-NBOMe) 4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe) 4-bromo-2,5-dimethoxybenzeneethanamine (2C-B)

[Repealed, 2012, c. 1, s. 45] Methylphenidate (α–phenyl–2–piperidineacetic acid methyl ester) and any salt thereof Methaqualone (2–methyl–3–(2–methylphenyl)–4(3H)–quinazolinone) and any salt thereof Mecloqualone (2–methyl–3–(2–chlorophenyl)–4(3H)–quinazolinone) and any salt thereof Lysergic acid diethylamide (LSD) (N,N–diethyllysergamide) and any salt thereof N,N–Diethyltryptamine (DET) (3–[(2–diethylamino) ethyl]indole) and any salt thereof N,N–Dimethyltryptamine (DMT) (3–[(2–dimethylamino) ethyl]indole) and any salt thereof N–Methyl–3–piperidyl benzilate (LBJ) (3–[(hydroxydiphenylacetyl)oxy]–1–methylpiperidine) and any salt thereof Harmaline (4,9–dihydro–7–methoxy–1–methyl–3H–pyrido(3,4–b)indole) and any salt thereof Harmalol (4,9–dihydro–1–methyl–3H–pyrido(3,4–b)indol–7–ol) and any salt thereof Psilocin (3–[2–(dimethylamino)ethyl]–4–hydroxyindole) and any salt thereof Psilocybin (3–[2–(dimethylamino)ethyl]–4–phosphoryloxyindole) and any salt thereof N–(1–phenylcyclohexyl)ethylamine (PCE) and any salt thereof 1–[1–(2–Thienyl) cyclohexyl]piperidine (TCP) and any salt thereof 1–Phenyl–N–propylcyclohexanamine and any salt thereof Rolicyclidine (1-(1-phenylcyclohexyl) pyrrolidine) and any salt thereof Mescaline (3,4,5–trimethoxybenzeneethanamine) and any salt thereof, but not peyote (lophophora) 4–Methylaminorex (4,5–dihydro–4–methyl–5–phenyl–2–oxazolamine) and any salt thereof Cathinone ((–)–α–aminopropiophenone) and any salt thereof Fenetylline (d,l–3,7–dihydro–1,3–dimethyl–7–(2–[(1–methyl–2–phenethyl)amino]ethyl)–1H–purine–2, 6–dione) and any salt thereof 2–Methylamino–1–phenyl–1–propanone and any salt thereof 1–[1–(Phenylmethyl)cyclohexyl]piperidine and any salt thereof 1–[1–(4–Methylphenyl)cyclohexyl]piperidine and any salt thereof[Repealed, SOR/2016-73, s. 1][Repealed, 2012, c. 1, s. 46] Aminorex (4,5-dihydro-5-phenyl-2-oxazolamine) and any salt thereof Etryptamine (3-(2-aminobutyl)indole) and any salt thereof Lefetamine ((-)-N,N-dimethyl-α-phenylbenzeneethanamine) and any salt thereof Mesocarb (3-(α-methylphenethyl)-N-(phenylcarbamoyl)sydnone imine) and any salt thereof Zipeprol (4-(2-methoxy-2-phenylethyl)-α-(methoxyphenylmethyl)-1-piperazineethanol) and any salt thereof Amineptine (7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) and any salt thereof Benzylpiperazine [BZP], namely 1-benzylpiperazine and its salts, isomers and salts of isomers Trifluoromethylphenylpiperazine [TFMPP], namely 1-(3-trifluoromethylphenyl)piperazine and its salts, isomers and salts of isomers 2C-phenethylamines and their salts, derivatives, isomers and salts of derivatives and isomers that correspond to the following chemical description : any substance that has a 1-amino-2-phenylethane structure substituted at the 2’ and 5’ or 2’ and 6’ positions of the benzene ring by an alkoxy or haloalkoxy group, or substituted at two adjacent carbon atoms of the benzene ring which results in the formation of a furan, dihydrofuran, pyran, dihydropyran or methylenedioxy group — whether or not further substituted on the benzene ring to any extent, whether or not substituted at the amino group by one or two, or a combination of, methyl, ethyl, propyl, isopropyl, hydroxyl, benzyl (or benzyl substituted to any extent) or benzylene (or benzylene substituted to any extent) groups and whether or not substituted at the 2-ethyl (beta carbon) position by a hydroxyl, oxo or alkoxy group — and its salts and derivatives and salts of derivatives, including 4-bromo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25B-NBOMe) 4-chloro-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25C-NBOMe) 4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe) 4-bromo-2,5-dimethoxybenzeneethanamine (2C-B)

[Repealed, 2012, c. 1, s. 45] Methylphenidate (α–phenyl–2–piperidineacetic acid methyl ester) and any salt thereof Methaqualone (2–methyl–3–(2–methylphenyl)–4(3H)–quinazolinone) and any salt thereof Mecloqualone (2–methyl–3–(2–chlorophenyl)–4(3H)–quinazolinone) and any salt thereof Lysergic acid diethylamide (LSD) (N,N–diethyllysergamide) and any salt thereof N,N–Diethyltryptamine (DET) (3–[(2–diethylamino) ethyl]indole) and any salt thereof N,N–Dimethyltryptamine (DMT) (3–[(2–dimethylamino) ethyl]indole) and any salt thereof N–Methyl–3–piperidyl benzilate (LBJ) (3–[(hydroxydiphenylacetyl)oxy]–1–methylpiperidine) and any salt thereof Harmaline (4,9–dihydro–7–methoxy–1–methyl–3H–pyrido(3,4–b)indole) and any salt thereof Harmalol (4,9–dihydro–1–methyl–3H–pyrido(3,4–b)indol–7–ol) and any salt thereof Psilocin (3–[2–(dimethylamino)ethyl]–4–hydroxyindole) and any salt thereof Psilocybin (3–[2–(dimethylamino)ethyl]–4–phosphoryloxyindole) and any salt thereof N–(1–phenylcyclohexyl)ethylamine (PCE) and any salt thereof 1–[1–(2–Thienyl) cyclohexyl]piperidine (TCP) and any salt thereof 1–Phenyl–N–propylcyclohexanamine and any salt thereof Rolicyclidine (1-(1-phenylcyclohexyl) pyrrolidine) and any salt thereof Mescaline (3,4,5–trimethoxybenzeneethanamine) and any salt thereof, but not peyote (lophophora) 4–Methylaminorex (4,5–dihydro–4–methyl–5–phenyl–2–oxazolamine) and any salt thereof Cathinone ((–)–α–aminopropiophenone) and any salt thereof Fenetylline (d,l–3,7–dihydro–1,3–dimethyl–7–(2–[(1–methyl–2–phenethyl)amino]ethyl)–1H–purine–2, 6–dione) and any salt thereof 2–Methylamino–1–phenyl–1–propanone and any salt thereof 1–[1–(Phenylmethyl)cyclohexyl]piperidine and any salt thereof 1–[1–(4–Methylphenyl)cyclohexyl]piperidine and any salt thereof 4–bromo–2,5–dimethoxybenzeneethanamine and any salt, isomer or salt of isomer thereof[Repealed, 2012, c. 1, s. 46] Aminorex (4,5-dihydro-5-phenyl-2-oxazolamine) and any salt thereof Etryptamine (3-(2-aminobutyl)indole) and any salt thereof Lefetamine ((-)-N,N-dimethyl-α-phenylbenzeneethanamine) and any salt thereof Mesocarb (3-(α-methylphenethyl)-N-(phenylcarbamoyl)sydnone imine) and any salt thereof Zipeprol (4-(2-methoxy-2-phenylethyl)-α-(methoxyphenylmethyl)-1-piperazineethanol) and any salt thereof Amineptine (7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) and any salt thereof Benzylpiperazine [BZP], namely 1-benzylpiperazine and its salts, isomers and salts of isomers Trifluoromethylphenylpiperazine [TFMPP], namely 1-(3-trifluoromethylphenyl)piperazine and its salts, isomers and salts of isomers